Related stories
Eli Lilly Expects Mounjaro to Maintain U.S. Leadership
Finance chief Lucas Montarce said Mounjaro’s U.S. revenue gained 41% to $5 billion in the latest quarter and pointed to strength outside the U.S.
M impact | EARNINGS | Oct 29, 2026, 03:55 PM UTC
Merck Plans to Raise Revenue Forecast for Next Decade
Merck plans to raise its revenue forecast for the next decade, citing optimism about new medicines.
M impact | EARNINGS | Oct 29, 2026, 03:50 PM UTC
Lilly Says Bridge Program Boosts GLP-1 Sales and Supports Raised Guidance
Eli Lilly says its U.S. Bridge program is boosting sales of its GLP-1 drugs and was a key driver of its raised full-year revenue guidance. The program started in July.
M impact | EARNINGS | Oct 29, 2026, 03:50 PM UTC
ADAMA Reports Q3 Sales Down 4% to $897 Million
ADAMA reported third-quarter sales of $897 million, down 4%.
M impact | EARNINGS | Oct 29, 2026, 03:46 PM UTC
Howmet Raises Full-Year Guidance on Robust Aircraft-Parts Demand
Howmet raised its full-year forecasts, citing robust demand for aircraft parts.
M impact | EARNINGS | Oct 29, 2026, 03:46 PM UTC
Rafael Holdings Reports FY 2026 Revenue of $874K, Net Loss of $29.6M
The company’s attributable net loss narrowed from $30.5 million a year earlier, while its consolidated net loss was $28 million. Operating loss widened to $33.4 million.
M impact | EARNINGS | Oct 29, 2026, 03:45 PM UTC